Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina Kuenz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Results and Problems in Cell Differentiation|June 11, 2009
B cells and antibodies in MSMarkus Reindl, Bettina Kuenz, Thomas Berger
Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic biomarkers in multiple sclerosisBettina Kuenz, Florian Deisenhammer, Thomas Berger, et al.
Journal of Neuroinflammation|November 19, 2010
Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort studyPeter Lackner, Bettina Kuenz, Markus Reindl, et al.
Journal of Neuroimmunology|July 26, 2005
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosisBettina Kuenz, Andreas Lutterotti, Michael Khalil, et al.
Journal of Neuroimmunology|March 7, 2006
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatmentsMichael Khalil, Markus Reindl, Andreas Lutterotti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2011
Persistency of neutralizing antibodies depends on titer and interferon-beta preparationHarald Hegen, Manuel Schleiser, Claudia Gneiss, et al.
Plos One|July 4, 2008
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisBettina Kuenz, Andreas Lutterotti, Rainer Ehling, et al.
Journal of Neuroimmunology|October 19, 2006
Increased serum levels of soluble CD14 indicate stable multiple sclerosisAndreas Lutterotti, Bettina Kuenz, Viktoria Gredler, et al.
Journal of the Neurological Sciences|March 26, 2013
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseasesViktoria Gredler, Simone Mader, Kathrin Schanda, et al.
Journal of the Neurological Sciences|October 16, 2009
Features of intrathecal immunoglobulins in patients with multiple sclerosisFranziska Di Pauli, Viktoria Gredler, Bettina Kuenz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Results and Problems in Cell Differentiation|June 11, 2009
B cells and antibodies in MSMarkus Reindl, Bettina Kuenz, Thomas Berger
Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic biomarkers in multiple sclerosisBettina Kuenz, Florian Deisenhammer, Thomas Berger, et al.
Journal of Neuroinflammation|November 19, 2010
Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort studyPeter Lackner, Bettina Kuenz, Markus Reindl, et al.
Journal of Neuroimmunology|July 26, 2005
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosisBettina Kuenz, Andreas Lutterotti, Michael Khalil, et al.
Journal of Neuroimmunology|March 7, 2006
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatmentsMichael Khalil, Markus Reindl, Andreas Lutterotti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2011
Persistency of neutralizing antibodies depends on titer and interferon-beta preparationHarald Hegen, Manuel Schleiser, Claudia Gneiss, et al.
Plos One|July 4, 2008
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisBettina Kuenz, Andreas Lutterotti, Rainer Ehling, et al.
Journal of Neuroimmunology|October 19, 2006
Increased serum levels of soluble CD14 indicate stable multiple sclerosisAndreas Lutterotti, Bettina Kuenz, Viktoria Gredler, et al.
Journal of the Neurological Sciences|March 26, 2013
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseasesViktoria Gredler, Simone Mader, Kathrin Schanda, et al.
Journal of the Neurological Sciences|October 16, 2009
Features of intrathecal immunoglobulins in patients with multiple sclerosisFranziska Di Pauli, Viktoria Gredler, Bettina Kuenz, et al.
Pageof 2